Infection of mice with Pseudomonas aeruginosa, washed and unwashed, mucoid and nonmucoid, altered subsequent immunity to Listeria monocytogenes. Mice were protected against lethal doses of L. monocytogenes yet exhibited decreased delayed-type hypersensitivity footpad swelling to sublethal doses. The mucoid coating of mucoid P. aeruginosa, an important pathogen in chronic bronchopulmonary disorders, imparted no additional immunomodulating capabilities to P. aeruginosa.
Numerous microorganisms and their products have been reported to influence the cell-mediated immune (CMI) response of a host to subsequently administered heterologous antigens (9, 22) , with both potentiation and suppression being reported. Recently, Pseudomonas aeruginosa has been investigated as an immunosuppressive agent and has been shown to suppress contact sensitivity to oxazolone in mice (3, 4) , to depress tuberculin sensitivity in guinea pigs (8) , to suppress homograft rejection in humans (24) and animals (8) , and to decrease in vitro DNA synthesis of human lymphocytes (21) . Petit et al. (19) , using a murine adoptive transfer system, found that both CMI to Listeria monocytogenes and delayed-type hypersensitivity (DTH) footpad swelling to sheep erythrocytes were decreased by prior P. aeruginosa immunization. In the study reported here, a modification of the Petit system was used to compare the effects of nonmucoid and mucoid P. aeruginosa infection upon immunity to subsequently administered L. monocytogenes, a bacterium against which CMI is the major host defense mechanism.
Mucoid P. aeruginosa, although a rare clinical isolate in the general population, is found in the lungs of patients with cystic fibrosis (12, 25) and other chronic bronchopulmonary disorders (20) . Once established, mucoid P. aeruginosa is virtually impossible to eradicate with therapy, and the clinical course of the patient deteriorates (12, 25) . This unique mucoid coating, which is characterized as an alginic acid, has been postulated to have antiphagocytic and virulence roles (12) . The present report will evaluate the immunosuppressive capacity of this mucoid-coated bacterium.
The loosely bound mucoid coating is removed by the washing procedures used to prepare bacteria for injection, and the bacteria require time to regenerate this exopolysaccharide (5). Because there is evidence that clearance of washed and unwashed mucoid P. aeruginosa differs at early times after infection (11; submitted for publication), unwashed organisms were included in this study to ensure maximum opportunity for mucoid production.
The clinical mucoid P. aeruginosa isolate used in this study and its nonmucoid revertant have been characterized previously in reference 2 monocytogenes. There were no differences noted in either strain among the four P. aeruginosa groups.
Although the suppression of DTH footpad swelling and the increased resistance to lethal infection with L. monocytogenes reported here for mice infected with P. aeruginosa may appear dichotomous, these results confirm those of previous studies. Galleli et al. (10) , using lipopolysaccharide in place of P. aeruginosa, reported the same results with subsequent Listeria infection. In vitro treatment of lymphocytes with concanavalin A increased transfer of antilisterial immunity but not DTH (1). In addition, Corynebacterium parvum, Mycobacterium sp., Freund adjuvant, and numerous metazoan and protozoan parasites which are classically considered adjuvants have been shown to depress CMI under certain experimental conditions (9, 22) .
Although Petit et al. (19) saw suppression of CMI to L. monocytogenes by prior P. aeruginosa infection, they used an adoptive transfer system with intravenously administered P. aeruginosa in their study. The intraperitoneal route within a single animal was used in the present study. An additional variable within this study was the size of the Listeria dose: depression of DTH to a sublethal dose was noted, whereas protection was seen in response to a lethal dose. These findings emphasize the finely balanced nature of the immune system and the importance of experimental conditions in altering this balance of suppression and potentiation.
Two questions arise regarding the immune alterations induced by P. aeruginosa: what is the effector mechanism for these phenomena, and what is the nature of the immunomodulating component? Petit et al. (19) presented evidence for a suppressor macrophage that inhibits subsequent immunity, and others postulated a suppressor B cell which interferes with T-lymphocyte-macrophage interactions (3, 4) . The suppressor T cell, too, is a possible candidate for a critical suppressing cell. The mechanism of suppression is, therefore, unclear and may differ with the experimental system. To explain the contradictory findings observed in their system, Galleli et al. (10) postulated a stimulation of macrophages by lipopolysaccharide, which increased protection against L. monocytogenes, and an interference with T lymphocytes, which depressed DTH. Similarly, Petit et al. (19) concluded that the macrophagemediated immune inhibition they observed may actually be due to activated macrophages with enhanced phagocytic ability. Czuprynski et al. (7) recently reported that unimmunized peritoneal neutrophils and macrophages, stimulated nonspecifically with proteose peptone and other agents, were as effective at listerial killing as stimulated phagocytes from immunized mice. Although this activity was maximal 4 h after injection for neutrophils and 48 h after injection for macrophages, bactericidal activity was evident at 24 h. The current study supports the theory. Prior P. aeruginosa infection may result in increased clearance of a lethal dose of L. monocytogenes so that the animal is protected, but if the antigen was sufficiently catabolized rather than processed and presented to T lymphocytes for activation, the mouse may be suboptimally sensitized. Because footpad swelling in mice injected with P. aeruginosa and L. monocytogenes was increased over unimmunized controls, although less than that seen with L. monocytogenes alone, the animals were sensitized to L. monocytogenes, but suboptimally.
The nature of the immunomodulating component of P. aeruginosa is speculative. Petit et al. (19) reported depression of immunity with both heat-killed preparations of P. aeruginosa and culture supernatants, so viable, replicating bacteria were not necessary. Lipopolysaccharide and endotoxin can both affect antilisterial immunity in responder mouse strains (10, 17) . Although the C3H/HeJ strain is hyporesponsive to lipopolysaccharide and endotoxin, the C3H/HeN strain used in these studies is a responder strain (6). Specific P. aeruginosa phenazine pigments can directly inhibit lymphocyte proliferation in vitro (23) . The P. aeruginosa exotoxins, elastase, protease, and exotoxin A may all be considered virulence factors and may affect immune responsiveness (16, 26) . Exotoxin A recently has been reported to enhance antibody production in T-cell-deficient mice and to depress production in immunocompetent mice (13) . Protease and elastase (14) and P. aeruginosa slime (15) have been shown to interfere with polymorphonuclear activity, which may be necessary for a proper antilisterial response (7).
The alginate coating of mucoid P. aeruginosa has also been postulated to be a virulence factor (12) . The present study indicates that no additional increase or decrease in immune alteration occurs with mucoid versus nonmucoid bacterial infections, even with unwashed preparations which have mucoid production maximized. Because clearance of these two strains from a normal murine host was equal at 24 h but less for mucoid organisms at early times after infection (manuscript submitted for publication), a difference may be detected by giving L. monocytogenes at an earlier time after P. aeruginosa. Under the experimental conditions used here, however, the mucoid coating did not augment the increased protection or decreased DTH to L. monocytogenes observed after P. aeruginosa infection. 
